ActivBiotics' Death

ActivBiotics raised a round of funding on January 01, 2008. Investors include Dead.

ActivBiotics is focused on the development and commercialization of antibacterials for the treatment of acute and chronic disease. The Company is developing rifalazil - a potent broad spectrum antibio…

Articles about ActivBiotics' Death: